SCR-A0011

N/A

Report date: 2025/06/06 16:48:37

First In Class

Base Information

Drug NameSCR-A0011

Drug Alias NameSCR-A0011

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > CPT116 payload

Mechanisms of ActionAnti-CD276Anti-Hepatocyte growth factor receptorDNA topoisomerase I inhibitors

TargetsCD276 antigenHepatocyte growth factor receptorDNA topoisomerase I

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHainan Xiansheng Re Ming Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHainan Xiansheng Re Ming Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A